Menopause mood dips respond to even gentle exercise

Depression and anxiety can significantly affect women during the menopausal transition and menopause, and the standard options are hormone therapy, antidepressants and psychotherapy. Physical activity has been increasingly studied as an addition or alternative, but there has been no consensus about its role for menopausal women with these symptoms. Whether exercise helps at all, and whether a woman needs to train hard to get the benefit, are practical questions affecting a very large population. This review set out to pool the randomised evidence and answer both.

The researchers searched PubMed, Embase, Web of Science, the Cochrane Library and CINAHL for randomised controlled trials published before 8 April 2024, focusing on the effect of physical activity on depressive and anxiety symptoms in women in the menopausal transition and menopause. Study quality was assessed with the Newcastle-Ottawa Scale. Twenty-one studies involving 2020 participants supplied the data: nine covered depressive symptoms alone, one covered anxiety alone, and eleven covered both. The team pooled standardised differences between exercise groups and controls, and ran subgroup analyses by menopausal status and exercise intensity.

Physical activity groups showed significantly lower depressive symptoms than controls, a moderate-sized effect, and significantly lower anxiety symptoms as well. In subgroup analyses, depressive symptoms improved in women in menopausal status, in postmenopausal status, and in mixed groups spanning both. Anxiety symptoms, by contrast, improved significantly only in postmenopausal women. Both low-intensity and moderate-intensity exercise produced benefits for depressive and anxiety symptoms, and there was no statistically significant effect of exercise intensity on either outcome. Several of the subgroup results came with substantial disagreement between the underlying trials.

This pooling builds a case where there was previously no consensus, positioning physical activity as a credible option alongside hormone therapy, antidepressants and psychotherapy for mood symptoms in menopause. The finding that intensity did not significantly change the outcome is notable, because it lowers the barrier to entry. The evidence base still has soft edges: the trials varied considerably in their results, the anxiety data are thinner than the depression data, and the review cannot say which types of activity, doses or durations work best. Those remain open questions for future trials.

For women navigating the menopausal transition or life after menopause, this is a reason to think regular movement is associated with genuinely better mood, not just better fitness. The absence of an intensity effect matters: the pooled data suggest gentle activity delivered benefits comparable to moderate exercise, so the evidence does not demand hard training. The anxiety benefit showed most clearly after menopause, while the depression benefit appeared across stages. As ever with pooled trials this size, the direction is more trustworthy than the precise magnitude.